Page last updated: 2024-10-29

indolepropionic acid and Non-alcoholic Fatty Liver Disease

indolepropionic acid has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

indolepropionic acid: structure in third source
3-(1H-indol-3-yl)propanoic acid : An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
" One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)."9.22Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. ( de Mello, VD; Lindström, J; Männistö, V; Pihlajamäki, J; Sehgal, R; Tuomilehto, J; Uusitupa, M, 2022)
" One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)."5.22Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. ( de Mello, VD; Lindström, J; Männistö, V; Pihlajamäki, J; Sehgal, R; Tuomilehto, J; Uusitupa, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sehgal, R1
de Mello, VD1
Männistö, V1
Lindström, J1
Tuomilehto, J1
Pihlajamäki, J1
Uusitupa, M1

Reviews

1 review available for indolepropionic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.
    Nutrients, 2022, Nov-06, Volume: 14, Issue:21

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bacteria; Diabetes Mellitus, Type 2; Humans; Liver; N

2022